Radcliffe Medical Education is hosting a symposium entitled 'Precision in Practice: Navigating Amyloidosis Diagnosis and Referral' at the Heart Failure Association (HFA) in Serbia, RS, on Saturday 17 May 2025 at 12:30 - 13:30 CEST. 
 

Overview 
In this symposium we join Dr Margot Davis (Vancouver, CA), Prof Fabian Knebel (Berlin, DE), Dr Aleksandar Aleksandrov (Berlin, DE) and Prof Olivier Lairez (Toulouse, FR) as they unpack a recent, real life patient referral. In this unique programme, we will explore the challenges faced during the referral process and then evaluate the practical steps for making a confident diagnosis. At the end of the session, we will revisit the case and consider future management strategies. 

This session has been designed to provide an assessment of the challenges often encountered during the referral and diagnosis of ATTR-CM. As such, we aim to provide practical guidance aimed at both the general cardiologist and amyloidosis specialist alike. 
 

Learning Objectives 
After attending this symposium, physicians will be able to:

• Navigate existing barriers that prevent identification and referral of suspect ATTR-CM cases
• Relate the benefits of early diagnosis with outcomes in terms of clinical and non-clinical endpoints
• Recall recent prevalence estimates for ATTR-CM in the community and amongst heart failure populations
• Review the most recent guidance around diagnosis, including use of imaging and genetic testing
• Be familiar with the current and future treatment landscape
   

Programme 
Part 1 - Patient Case Presentation
Part 2 - Referral: Specialist Discussion
Part 3 - Outcomes and Epidemiology of Community Dwellers 
Part 4 - Practical Diagnosis: Ruling Out and Confirming ATTR
Part 5 - Patient Case Revisited and Future Management Strategies 
Part 6 - Your Questions Answered
 

This satellite symposium is supported by an unrestricted educational grant from AstraZeneca who had no involvement in the content.